These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 20737205)
21. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358 [TBL] [Abstract][Full Text] [Related]
22. Association of STXBP4/COX11 rs6504950 (G>A) polymorphism with breast cancer risk: evidence from 17,960 cases and 22,713 controls. Tang L; Xu J; Wei F; Wang L; Nie WW; Chen LB; Guan XX Arch Med Res; 2012 Jul; 43(5):383-8. PubMed ID: 22863968 [TBL] [Abstract][Full Text] [Related]
23. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151 [TBL] [Abstract][Full Text] [Related]
24. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis. Yao L; Fang F; Zhong Y; Yu L Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503 [TBL] [Abstract][Full Text] [Related]
25. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Ma Y; Tang RK; Yang X; Peng GG; Liu Y; Wang XM; Wu BH; Yu JM Hum Immunol; 2011 Aug; 72(8):641-51. PubMed ID: 21536090 [TBL] [Abstract][Full Text] [Related]
26. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis. Cao HY; Zou P; Zhou H Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354 [TBL] [Abstract][Full Text] [Related]
27. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343 [TBL] [Abstract][Full Text] [Related]
28. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects. Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154 [TBL] [Abstract][Full Text] [Related]
29. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis. Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603 [TBL] [Abstract][Full Text] [Related]
30. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects. Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk. Liang Y; Xu WD; Zhang M; Qiu LJ; Ni J; Wang XS; Wen PF; Cen H; Leng RX; Pan HF; Ye DQ Int J Rheum Dis; 2013 Dec; 16(6):616-24. PubMed ID: 24267724 [TBL] [Abstract][Full Text] [Related]
32. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051 [TBL] [Abstract][Full Text] [Related]
33. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study. He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156 [TBL] [Abstract][Full Text] [Related]
34. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Wang AH; Lam WJ; Han DY; Ding Y; Hu R; Fraser AG; Ferguson LR; Morgan AR Hum Immunol; 2011 May; 72(5):431-5. PubMed ID: 21354456 [TBL] [Abstract][Full Text] [Related]
35. Association of interleukin-10 gene promoter polymorphisms with recurrent pregnancy loss: a meta-analysis. Gu C; Gong H; Zhang Z; Yang Z; Ma Y J Assist Reprod Genet; 2016 Jul; 33(7):907-17. PubMed ID: 27022931 [TBL] [Abstract][Full Text] [Related]
36. The -1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis. Zhang J; Zhang Y; Jin J; Li M; Xie K; Wen C; Cheng R; Chen C; Lu J Cytokine; 2011 Nov; 56(2):351-5. PubMed ID: 21764596 [TBL] [Abstract][Full Text] [Related]
37. Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis. Jiang Z; Li C; Xu Y; Cai S; Wang X Breast Cancer Res Treat; 2010 Aug; 123(1):203-12. PubMed ID: 20111903 [TBL] [Abstract][Full Text] [Related]
38. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Ahirwar D; Mandhani A; Mittal RD Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018 [TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G; Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]